A new market study, titled “Global Oncolytic Virus Therapy Market Size study, by Type (Oncolytic Wild Type Viruses, Genetically Engineered Oncolytic Viruses), by Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer) and Regional Forecasts 2018-2025” has been featured on WiseGuyReports.
The Oncolytic Virus Therapy Market is continuously growing across the world over the coming years. The major driving factor of global oncolytic virus therapy market are rising adoption of diagnostic & therapeutics procedure and increase in the number of patients with cancers. The major restraining factor of global oncolytic virus therapy market are lack of awareness among users and new class of anticancer immunotherapy. Oncolytic virus therapy is a virus that preferentially infects and kills cancer cells are destroyed by oncolysis, they extract new infectious viral particles to destroy the remaining tumor. The oncolytic viruses conduct the twice functions as they are not causing only the destruction of cancer infected cells but also stimulate the host anti-tumor immune response & don’t allow the expansion of tumor cells.
The regional analysis of Global Oncolytic Virus Therapy Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to well-developed healthcare infrastructure with massive investment in R&D of oncolytic virus immunotherapy. Europe also contributes a satisfactory growth in the global oncolytic Virus therapy market. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 due to increased government initiatives.
The major market player included in this report are:
- Biovex
- Cell Genesys
- Crusade Laboratories
- Genelux Corporation
- Lokon Pharma
- Merck
- MultiVir
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Oncolytic Wild Type Viruses
Genetically Engineered Oncolytic Viruses
By Application:
Breast Cancer
Lung Cancer
Prostate Cancer
Melanoma
Brain Tumor
Blood Cancer
Request Sample Report at https://www.wiseguyreports.com/sample-request/3606297-global-oncolytic-virus-therapy-market-size-study-by
By Regions:
North America
o U.S.
o Canada
Europe
o UK
o Germany
Asia Pacific
o China
o India
o Japan
Latin America
o Brazil
o Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
Target Audience of the Global Oncolytic Virus Therapy Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Oncolytic Virus Therapy Market Definition and Scope
Chapter 3. Oncolytic Virus Therapy Market Dynamics
Chapter 4. Oncolytic Virus Therapy Market Industry Analysis
Chapter 5. Oncolytic Virus Therapy Market, by Type
Chapter 6. Oncolytic Virus Therapy Market, by Application
Chapter 7. Oncolytic Virus Therapy Market, by Regional Analysis
Chapter 8. Competitive Intelligence
Chapter 9. Research Process
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)